BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wang A, Shen J, Rodriguez AA, et al. (2023) Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nature Genetics |
Darst BF, Shen J, Madduri RK, et al. (2023) Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry. American Journal of Human Genetics |
Thorn JC, Turner EL, Walsh EI, et al. (2023) Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP). Bmc Health Services Research. 23: 610 |
Darst BF, Shen J, Madduri RK, et al. (2023) Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry. Medrxiv : the Preprint Server For Health Sciences |
Hamdy FC, Donovan JL, Lane JA, et al. (2023) Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. The New England Journal of Medicine |
Keeney E, Sanghera S, Martin RM, et al. (2022) Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial. Pharmacoeconomics |
Buhigas C, Warren AY, Leung WK, et al. (2022) The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates. Molecular Cancer. 21: 183 |
Huynh-Le MP, Karunamuni R, Fan CC, et al. (2022) Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score. Prostate Cancer and Prostatic Diseases |
Huynh-Le MP, Fan CC, Karunamuni R, et al. (2021) Polygenic hazard score is associated with prostate cancer in multi-ethnic populations. Nature Communications. 12: 1236 |
Emruli VK, Liljedahl L, Axelsson U, et al. (2021) Identification of a serum biomarker signature associated with metastatic prostate cancer. Proteomics. Clinical Applications. e2000025 |